Skip to main content
OpenTrials

Clinical trial condition

Small-cell Lung Cancer

Explore clinical trials studying Small-cell Lung Cancer. Study availability and eligibility vary by location and protocol.

75 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Small-cell Lung Cancer trial results

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

NCT04242199

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +67 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Upmc Cancercenter Pittsburgh, Pennsylvania, United States
  • Md Anderson Cancer Center Houston, Texas, United States
View all 21 locations
View Trial Details
Completed

To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

NCT05253053

Conditions
Adenocarcinoma, Advanced Solid Tumor, Biliary Tract Cancer, +56 more
Locations
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
View Trial Details
Completed

A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer

NCT03532880

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Baptist Alliance Miami Cancer Institute Miami, Florida, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Completed

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

NCT03761914

Conditions
Acute Myelogenous Leukemia, Adnexal Diseases, Breast Diseases, +45 more
Locations
  • St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • Innovative Clinical Research Institute (ICRI) Whittier, California, United States
  • Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
View Trial Details
Completed

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

NCT03583086

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Providence Cancer Institute Franz Clinic Portland, Oregon, United States
View Trial Details
Completed

Berzosertib + Topotecan in Relapsed Platinum-Resistant Small-Cell Lung Cancer (DDRiver SCLC 250)

NCT04768296

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Congenital Abnormalities, +19 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • St Joseph Heritage Healthcare Santa Rosa, California, United States
  • Cotton-O'Neil Clinical Research Center, Hematology and Oncology Topeka, Kansas, United States
  • National Cancer Institute Bethesda, Maryland, United States
View all 51 locations
View Trial Details
Completed

Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

NCT04742959

Conditions
Adenocarcinoma, Advanced Solid Tumor, Biliary Tract Diseases, +57 more
Locations
  • City of Hope Duarte, California, United States
  • The University of Chicago Chicago, Illinois, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
View Trial Details
Completed

A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)

NCT04834778

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +36 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • HealthPartners Cancer Care Center Saint Paul, Minnesota, United States
  • Baylor University Medical Center Dallas, Texas, United States
  • The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions